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Abstract In this paper, we affirm our earlier findings of evidence for a limit to
human lifespan. In particular, we assess the analyses in extreme value theory
(EVT) performed by Rootze´n and Zholud. We find that their criticisms of our
work are unfounded and that their analyses are contradicted by several other
papers using EVT. Furthermore, we find that even if we completely accept the
conclusions about late-life human mortality reached by Rootze´n and Zholud,
their results do not actually contradict the findings presented in our original
paper: whether unbounded or not, human lifespan is unlikely to greatly exceed
120 years, and the improbability of longer survival—whether it is exactly zero
or merely astronomically small—acts as a de facto limit. In order to eliminate
the confusion surrounding the issue, we propose the adoption of the term
“limit” to denote the age at which the chance of survival is exactly zero and
the term “effective limit” to denote the age at which the change of survival falls
below a given threshold. Once this distinction is made, it can be demonstrated
that the final result of Rootze´n and Zholud is essentially a recapitulation of the
main conclusion of our paper. Ultimately, much of the controversy surrounding
the issue of a limit to human lifespan can be avoided by carefully reading the
literature and applying statistics to practical human scales.
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2 Brandon Milholland et al.
1 Introduction
In their paper [10], Rootze´n and Zholud assert that there is no limit to human
lifespan and also level several criticisms at our paper [1] in which we reported
evidence for such a limit. Harsh words, such as “unfounded”, “inappropriate”,
“wrong” and “misleading” are used, but the severity of their language belies
the fact that their paper is the one that is misleading by misrepresenting our
findings and attacking us on tenuous, incorrect and unfounded bases (Section
2). A close examination of the work of Rootze´n and Zholud will reveal that
their analysis is inadequate to conclusively demonstrate that human lifespan
is unlimited (Subsection 3.1). Furthermore, several other analyses have come
to conclusions the opposite of Rootze´n and Zholud (Subsection 3.2). Finally,
even Rootze´n and Zholud’s own work suggests that there is a de facto limit
to human lifespan, one that is not much higher than the one we found in
our original paper (Section 4). In one very narrow sense—one that we did
not propose at all in our paper—human lifespan may be unlimited. But, in a
much more practical and reasonable sense, human lifespan, given the current
paradigm of medical research, is limited.
2 Refuting the criticisms of Rootze´n and Zholud
In Section 4 of their paper, Rootze´n and Zholud summarily dismiss the the
results presented in our paper poiting to a limit to human lifespan [1] in four
brief paragraphs1. These paragraphs only address Figure 2 of our paper and
do not address the findings presented in Figure 1 and Extended Data Figures
1, 2, 3, 4, 5 and 6 of our paper. In these four crucial paragraphs, Rootze´n
and Zholud begin with a falsehood, move on to a potential self-contradiction,
make a nonsensical statement, and finally conclude by fundamentally misun-
derstanding the thesis of our paper.
In the first paragraph, Rootze´n and Zholud state that the number of su-
percentenarian deaths in the International Database of Longevity (IDL) varies
from 0 to 42. However, this statement is false: it is plain to see from Rootze´n
and Zholud’s Figure 6 and Figure 7 that the minimum number of deaths in
any year is 1.
1 Rootze´n and Zholud also cursorily mention our findings that improvements in mortality
decrease with age and argue that “ a slower rate of improvement is still an improvement,
and, if anything, it contradicts the existence of a limit”, but this assertion is never backed
up by any evidence or reasoning. A slower rate of increase does not imply that the increase
will continue forever, nor does it imply that there is no limit. By Rootze´n and Zholud’s
logic, an examination of some partial sums of the series
∑n
i=1 2
−i would show a slowing
rate of increase as n increases, which “if anything . . . contradicts the existence of a limit”.
However, it has been mathematically proven that geometric series in this form converge (i.e.,
limn→∞
∑n
i=1 2
−i = 1), so there is in fact a finite limit to the sum. Furthermore, Rootze´n
and Zholud do not address the fact that that there has been not merely a deceleration of
improvement but an absence of any detectable improvement whatsoever in supercentenarian
mortality.
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Rootze´n and Zholud also assert in the first paragraph of Section 4 that the
yearly maximum reported age at death (MRAD) “shows the same pattern”
as the number of deaths; unfortunately, they do not provide any correlation
statistics that could be used to evaluate that assertion. In the next paragraph,
they mention a different line (representing 110+ mean of maximum nt ex-
ponential variables) that they also assert, without statistical substantiation,
“agree[s] well” with the MRAD, but this line differs greatly from the line rep-
resenting the number of deaths (most visible in the interval 1990–2000). It
would seem contradictory that the line representing number of deaths, which
fluctuates in magnitude several-fold over short periods of time (for example,
leaping from 5 to 35 in the early 1990s), and the line representing 110+ mean
of maximum nt exponential variables, which is devoid of such wild fluctua-
tions (barely ambling from around 113 to around 115 over the same interval),
could both strongly correlate with the MRAD. Perhaps the graphs are mis-
leading, and both variables, counterintuitively, manage to correlate well with
the MRAD, but Rootze´n and Zholud provide no statistical evidence that they
do.
In the third paragraph, Rootze´n and Zholud say that our findings result
from “inappropriate combination of data from different time periods”. This
does not make sense: we merely used all the data from the entire time inter-
val of the IDL (and, separately, the GRG). Presumably, they meant to say
that there was an inappropriate combination of data from different countries
since that is the issue they touch upon at the end of the previous paragraph.
However, considering each country separately still finds evidence for a trend
break, contrary to Rootze´n and Zholud’s assertion. In Japan, all of the data
is post-breakpoint, so there is no evidence for or against, although the num-
ber of supercentenarian deaths does increase more rapidly than the MRAD,
suggesting the two have become decoupled. In the USA, the increase of the
MRAD continues unabated, providing some evidence against a trend break;
but note also the sharp jump in the number of supercentenarian deaths in the
early 1990s and the comparatively shallower increase in MRAD, again under-
mining Rootze´n and Zholud’s thesis that the MRAD is driven by number of
supercentenarian deaths. In England and Wales, the slope of the trend de-
creases from 0.7 to 0.2. Rootze´n and Zholud do not define what evidence is
sufficient to indicate a trend break, prompting the question: if a more than
3-fold decrease in the slope is not evidence for a trend break, then what is?
Finally, in France the slope goes from 0.2 to –0.3, indisputable evidence of a
trend break. To summarize, of the four countries considered, one of them is
invalid, one arguably does not have a trend break, and two almost certainly do.
Furthermore, all four contain fluctuations in the number of supercentenarian
deaths not reflected in the MRAD. Therefore, the balance of evidence favors
the conclusions presented in our original paper.
The final paragraph dismisses the evidence of a limit in the 2nd through
5th highest reported ages at death with a repetition of the nonsensical accu-
sation of “inappropriate combination of data from different time periods” and
no substantiating evidence. Given the weakness of the reasoning employed by
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Rootze´n and Zholud regarding the MRAD, it is likely that this assertion re-
garding the 2nd through 5th highest deaths is not supported by the evidence,
but their thesis is ultimately impossible to evaluate due to the absence of in-
formation provided in the paper. Section 4 of Rootze´n and Zholud’s paper
terminates with a fundamental misinterpretation of the thesis of our paper.
The main observation of our paper was that the MRAD had stagnated since
the mid-1990s and, despite advances in medicine, fluctuated around 115, with-
out further increase; this stagnation around the average of 115 constitutes the
“limit” referred to in our paper. As a corollary, if one desires to know the
absolute highest age to which any human could reasonably expect to live,
then we also calculated that an MRAD of more than 125 would be expected
only once every 10,000 years; this value may also be considered a “limit” to
human longevity. In short, the term “limit” is overloaded, and can refer to
distinct, yet related, concepts depending on context. In their paper, Rootze´n
and Zholud introduce a third definition of “limit”: the point at which the
chance of survival is equal to zero. They contend that since the distribution of
MRAD ages is unbounded, there is no “limit” to human lifespan. On its own,
there is nothing fundamentally wrong with this contention, but the failure of
our paper to conform to the arbitrarily altered definition of “limit” formulated
by Rootze´n and Zholud cannot be considered an error on our part. Indeed,
as we will see, the definition of “limit” used by Rootze´n and Zholud is not
very useful, as it would apply even to situations in which the probability of
survival is so small as to be negligible. From a very philosophical perspective,
it is possible to argue that due to the inherently stochastic nature of the uni-
verse implied by quantum physics, it is impossible to ever assign a probability
of zero to any event, so the conclusion reached by Rootze´n and Zholud is not
novel. Rootze´n and Zholud build their paper on a more immediately applicable
starting point—demographic data—but if their goal was to derive the conclu-
sion of no limit to lifespan based on that foundation alone, they have made
several omissions and questionable decisions that undermine the strength of
their analyses.
3 Problems with the analyses of Rootze´n and Zholud and
literature contradicting their results
Having made our reply to the criticisms Rootze´n and Zholud leveled against
our paper, we move on to several of our own criticisms of their paper. The
conclusion reached by Rootze´n and Zholud—that human life is “unlimited”—
is extraordinary, even if qualified by “but short”. Such a strong conclusion
requires strong evidence, but that which is presented by Rootze´n and Zholud
is not up to the task. Furthermore, the conclusions reached by Rootze´n and
Zholud put them at odds with multiple other papers, not just our own. These
contradictions must be resolved before the contention of an unlimited human
lifespan can be accepted.
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3.1 Problems with the analyses of Rootze´n and Zholud
Much of the work in Rootze´n and Zholud’s paper is of good quality, but there
are several areas where they use statistics inappropriately or come to conclu-
sions that do not necessarily follow from the premises given. These deficiencies
do not discredit the entire paper, but they significantly weaken the strength
of the findings presented therein. Indeed, it is possible that each could be ad-
dressed and a confirmation of Rootze´n and Zholud’s analysis found. Therefore,
we present these issues in the spirit of a scientific dialogue, in the hopes that
further investigation will advance our knowledge, either for or against Rootze´n
and Zholud’s conclusions.
First, the data used by Rootze´n and Zholud appear to support a stagna-
tion of supercentenarian mortality, with no improvement in supercentenarian
survival in recent decades, something that would be consistent with a limit to
human lifespan and not a continual improvement towards breaking that limit.
In Table 3 of their paper, Rootze´n and Zholud present the results of statisti-
cal tests in several sets of data for differences in supercentenarian mortality
between the first half of each set (generally spanning from the 1960s until
the 1990s) and the second half (generally from the mid-to-late 1990s until the
mid-to-late 2000s). In every single case, they find no evidence of a change in
mortality, with the lowest p-value being 0.18, not even close to significant.
This finding essentially confirms our earlier results[1], i.e. a lack of improve-
ment in supercentenarian mortality indicates that human lifespan has stopped
increasing, and is essentially a restatement of the finding presented in Figure
3c of our original paper.
Second, Rootze´n and Zholud have chosen an inappropriate null hypothesis
and incorrectly interpreted the results of their statistical tests. Rootze´n and
Zholud begin with the assumption that the force of mortality after age 110 is
constant, and that human lifespan therefore follows an exponential distribu-
tion. Then, they provide several p-values, in Table 5 of their paper, which fail
to reject this null hypothesis. However, it is basic knowledge regarding p-values
that a failure to reject the null hypothesis does not mean that the null hypoth-
esis is true. Furthermore, the assumption of a constant force of mortality is
not an appropriate null hypothesis. From early adulthood onwards, mortality
increases relentlessly; it is far more parsimonious to assume that this increase
will continue rather than that it will stop in its tracks at old age. Indeed, by
making a constant force of mortality (which corresponds to an “unlimited but
short” lifespan) their null hypothesis, Rootze´n and Zholud have committed
the fallacy of assuming that which was to be demonstrated. Finally, despite
having tilted the scales in favor of a constant force of mortality, Table 2 of
Rootze´n and Zholud’s paper indicates that the GRG dataset, the data with
the greatest temporal and geographic reach, strongly rejects the hypothesis of
an exponential distribution. Thus, the main premise of Rootze´n and Zholud’s
paper, that the force of mortality after age 110 is constant, is not supported
by the data and statistics presented.
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3.2 Contradictions with the literature
Having established that Rootze´n and Zholud failed to demonstrate a constant
force of mortality, we should not be too harsh. After all, the task they have set
out for themselves is impossible: showing that the force of mortality is constant
would require showing that there is no change in mortality, which would require
proving a negative. A more realistic goal would be to calculate a confidence
interval for the force of mortality after age 110 in order to establish an upper
bound for mortality. That has been done by others[8], and the upper bound of
the resulting interval rapidly approached 1. Although the confidence intervals
were wide, leading the authors of that paper to conclude that mortality after
age 100 plateaued, the fact that the estimate of mortality also rapidly increased
past 0.5 after age 110 and rapidly approached 1 indicates that the balance of
evidence is actually in favor of a limited lifespan as defined by Rootze´n and
Zholud. Furthermore, they found that centenarian mortality has not improved,
a result that strongly supports our findings of a limited human lifespan based
on MRAD. As the authors of that paper concluded: “the maximum lifespan,
measured as the age of the oldest person to die, is currently not increasing”.
Rootze´n and Zholud have used EVT in their attempt to resolve the ques-
tion of whether human lifespan is limited, reaching the conclusion that it is
unlimited. Three other recent papers have examined the same question using
EVT and come to the opposite conclusion. The first[4] examined data from
46,666 Belgians who died at 95 or older and found an “ultimate age” of 115
for men and 123 for women, a result very similar to our own. The second
paper[3] analyzed data from the International Database on Longevity (IDL)
and the Human Mortality Database (HMD). The authors of that paper write
that “due to its small sample size, the hypothesis of an infinite lifespan could
not be rejected for the IDL,” the dataset used by Rootze´n and Zholud, but
when they supplemented it with data from the HMD, “we found significant ev-
idence for a finite lifespan in the combined data set and obtained reliable point
estimates for the maximum attainable age” of 125–128 years in females. Fi-
nally, a paper[2] based on precise measurements of the ages at death of 285,000
residents of the Netherlands found “compelling statistical evidence” for a fi-
nite human lifespan in both men and women. They found an average annual
endpoint to the lifespan distribution of 114 and 116 years and a maximum es-
timated upper endpoint of 125 and 124 years in men and women respectively2.
These estimates are very close to the estimates of average MRAD, 115 years,
and maximum MRAD, 125 years, which we arrived at in our original paper.
2 The authors of that paper also found a lack of a trend in with time in these values;
although they imply that the lack of a trend would contradict our paper, this implication is
based on a misinterpretation of our results, which found an initial upward trend, followed by
a lack of a trend (and not necessarily a decrease, as indicated by the insignificant p-value)
during recent decades. Instead, the lack of a trend is a confirmation of our findings that
there has essentially been a limit in place the whole time, which was finally reached in the
mid-1990s.
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To summarize, all three of these other EVT papers confirm our results and
contradict those of Rootze´n and Zholud.
To conclude this section, we would like to use Rootze´n and Zholud’s con-
cluding sentences to tie together the two previous strands: the gaps in their
paper and its variance with the literature. In the penultimate and final sen-
tences of their paper, Rootze´n and Zholud concede that “the IDL data set only
includes 9 persons who lived longer than 115 years, so data is sparse above
this age” but assert that “these 9 data points agree well with our conclusion”.
No substantiation is given for this assertion, and the very sparsity of such data
is itself suggestive of a limit to human lifespan, but even if it were true that
those 9 data points did support Rootze´n and Zholud’s conclusion, they must
surely be outweighed by the contradictory studies based on over 300,000 data
points.
4 Shortness of life as a de facto limit: theoretical considerations
and empirical results
As we have shown, there is considerable evidence against Rootze´n and Zholud’s
conclusion that the force of mortality remains constant after age 110. However,
there still remains a slim possibility that they are correct. It is also possible
that the force of mortality could increase with age and asymptotically approach
1 without ever reaching it, such as in a sigmoid function (Figure 1), a scenario
not considered by Rootze´n and Zholud. In any case, let us assume that Rootze´n
and Zholud are correct there is no limit, L, beyond which the probability of
survival is 0. Would this contradict our results? And would it be a finding of
importance? The answer to both questions is: no.
First, a hard limit, with a chance of mortality equal to 1, was never part
of our original paper. As a commentary on our paper observed[9], our paper’s
thesis is that “there is no fixed limit beyond which humans cannot live, but that
there are, nevertheless, limits on the duration of life”; the “limit” referred not
to an age of certain death but the stagnation of advances in human maximum
lifespan and the corollary emergence of an age beyond which survival, although
not impossible, is prohibitively unlikely. To refer directly to the text of our
paper: “we found that the probability of an MRAD exceeding 125 in any
given year is less than 1 in 10,000”—not zero. In light of this, Rootze´n and
Zholud’s statement that “it is likely that the record age . . . will be shorter than
128 years” is neither contradictory to our conclusions nor particularly novel,
but rather a slightly different estimate of the number: stated informally (we
shall formalize it below), the age which MRAD is unlikely to exceed in the
foreseeable future.
The main thesis of Rootze´n and Zholud’s paper, that there is no “limit”
by their definition to human lifespan is not particularly meaningful or novel.
Indeed, it is not even necessary to consult any demographic data in order to
arrive at the conclusion that there is no age with a zero chance of survival.
According to quantum physics, anything is possible, even if extremely un-
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Fig. 1 The three trajectories of late-life mortality envisioned by Rootze´n and Zholud, and
one they do not consider, placed in context of the earlier exponential increase in mortality.
In the top left corner, the “limited” scenario, mortality increases exponentially throughout
life until it hits 1 (certain death). In the top right corner, the “unlimited but short” scenario,
mortality increases exponentially until it reaches 0.53 and then remains stationary. In the
bottom left corner, the “unlimited” scenario, mortality increases exponentially and then
decreases late in life. Finally, in the bottom right corner, the sigmoid scenario not considered
by Rootze´n and Zholud, mortality follows an approximately exponential increase early in
life until it begins to level off and asymptotically approach 1; mortality never reaches 1, but
it does not decline or stagnate and continues to increase at an ever-slower rate. Note the
lack of parsimony in both of the “unlimited” scenarios proposed by Rootze´n and Zholud.
likely. So, the odds of a brain spontaneously appearing out of thin air due to
quantum fluctuations have been calculated[5] to be 1 in 1010
50
. Since aging
is due to physical changes, i.e. the accumulation, depletion or modification
of macromolecules[6], it is possible that quantum fluctuations could sponta-
neously transform a supercentenarian’s body to that of a 20 year old, making
them a shoo-in for a new longevity record. Calculating the exact probability
of this event occurring, and the question of whether the number of zeros in its
decimal representation would exceed the number of atoms in the observable
universe, we leave as an exercise for future investigators.
In case the scenario described above strikes readers as too outlandish, we
propose a more realistic occurrence based on Rootze´n and Zholud’s model
of “unlimited” lifespan: assuming that Rootze´n and Zholud are correct and
mortality after age 110 follows the “each year a coin is tossed” model, and
rounding3 up the probability of survival to 50%, the odds of a supercentenarian
living to age 150 are 1 in 240 or just under 1 in a trillion. So, on the one hand
we are told that “human life is unlimited” and on the other hand the same
3 Observant readers will note that the abstract of Rootze´n and Zholud’s paper is con-
tradicted by its body: in the former, the probability of dying is given as 47%, while in the
latter that value is given as the probability of survival. While mixing up life and death is a
major error, the proximity of both probabilities to 50% limits its effects.
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Table 1 Values of Le and  inferred from other publications.
Le  Data source Citation
114.9 0.5 IDL/GRG [1]
125 0.0001 IDL/GRG [1]
131.21  0.025 Belgian National Population Register [4]
128.73  0.025 IDL/HMD [3]
115.7 0.5 Statistics Netherlands [2]
123.7 0.025 Statistics Netherlands [2]
115 0.5 “Best-guess” MRAD [7]
128 ? IDL/GRG [10]
model gives probabilities of survival that are so low that many would consider
them next to impossible. At a certain point, discussing the probability of a
single individual living to a given age under Rootze´n and Zholud’s “unlimited”
lifespan paradigm becomes akin to discussing the probability of receiving a
single molecule of the active ingredient from a homeopathic remedy.
Our point is that the finding that human lifespan is “unlimited” on the ba-
sis that there is no age with a zero chance of survival may be mathematically
true and it may be of theoretical or even recreational interest, but it is of little
practical significance or use. Insisting that a “limit” to lifespan consist of an
age with 100% mortality gives the term “limit” too narrow and restrictive a
definition, one we did not use in our original paper and one that makes any
statements regarding its existence or nonexistence almost completely inconse-
quential. Instead of discussing the limit, L, of lifespan as the age with a zero
chance of survival, we propose that future discussions of extreme longevity fo-
cus on the effective limit, Le of lifespan, the age beyond which it is extremely
unlikely any individual of the species will survive. The value of Le will depend
on many factors, the most pressing of which is the definition of “extremely un-
likely”. Therefore, Le can be stated formally by qualifying it with , the desired
definition of “extremely unlikely”. For example, our original paper calculated
L=0.0001e = 125, i.e. the probability of any human surviving past 125 is 0.0001
or 1 in 10,000. In their paper, Rootze´n and Zholud essentially calculate Le to
be 128, but do not provide the value of  they used. The values of Le and 
can be inferred from other publications (Table 1). Generally, L=0.5e is around
115, while values of Le for lower values of  are in the mid-120s.
The value of Le, for a given value of , is not constant. It is determined
by two factors: the population of the species (more individuals means more
chances for one of them to reach an extreme age) and the chance of survival
at each age leading up to Le. In our original paper, we came to the con-
clusion that Le had basically reached its limit—here, meaning that Le had
remained for years and would remain in the absence of unprecedented techno-
logical breakthroughs at its current level—based on the tacit assumption that
the human population would not greatly increase and our explicit demonstra-
tion that late-life survival had stagnated. Rootze´n and Zholud speculate that
future research may further extend human lifespan, and we do the same in
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the conclusion of our original paper, stating that “there is no scientific reason
why such efforts could not be successful”. However, the gains from such efforts
have not been realized. There is currently no cure for aging, nor is there even
a product approved to be marketed as a treatment for aging. Perhaps one day
human lifespan will become unlimited, but right now the chances of mortality
at old age act as an effective limit to lifespan.
5 Conclusion
The premise and even the title of Rootze´n and Zholud’s paper are self-contradictory:
“human life is unlimited — but short”. We resolve this contradiction by posit-
ing that the shortness of human life constitutes its limit. For a particular,
narrow definition of “limit” it can indeed be said that there is no limit to
human lifespan, but for a more useful definition there is one. If one finds it
justified to say that human life is “unlimited” because there is a constant
47% chance of survival each year, one must also find it justified to say that
roulette winnings are “unlimited” because there is a constant 48.7% chance
of doubling one’s money by betting on black every time. It is easy to see the
problem with relying on the latter reasoning for a moneymaking strategy, so
why would anyone accept the former reasoning for a longevity strategy?
The use of an overly restrictive definition of “limit” (as detailed in Section
4) is not the only issue with Rootze´n and Zholud’s paper. They also make
unfounded criticisms of our findings of evidence for a limit to human lifespan
(refuted in Section 2) and the evidence even for their modest conclusion is
weak, with both statistical issues undermining their findings (enumerated in
Subsection 3.1) and larger studies having contradictory results (reviewed in
Subsection 3.2). Thus, the contention that “human life is unlimited” is most
likely to be false.
Much of the controversy surrounding this issue could have been avoided by
carefully reading our paper and using the context of the word “limit” as we
used it to correctly infer its meaning in that paper. Imposing an inappropriate
definition of the word does not contribute to the literature, as it seeks to rebut
our paper for a thesis it does not actually advance.
However, there is some value to Rootze´n and Zholud’s work, as it has
drawn attention to the necessity of explicitly formulating a definition of “lim-
ited” that is useful for discussions of human lifespan. Although the evidence
available suggests that, contrary to Rootze´n and Zholud’s conclusion, the risk
of mortality does not remain constant after age 110, there also is no age at
which mortality is certain. In that sense, then, human life is unlimited: for an
infinitely large cohort or for an infinitely many cohorts, there is no maximum
age beyond which no individual will live. However, for finitely-sized cohorts,
observed over a sensible interval of time (10,000 years, being a few times longer
than the duration of recorded civilization, is probably the absolute maximum
that can be seriously considered) the age-related elevation of mortality acts to
constrain the highest age that is likely to be observed, with estimates of that
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constraint clustering around 125. In order to distinguish between these two
concepts, we proposed the term “effective limit” to indicate the age at which
the probability of a single individual surviving is negligible (falling below a
given threshold). We hope that this new term will be useful in facilitating
clear and meaningful discussion of longevity in the future.
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